Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of the Impact of Injecting an Autologous Somatic Mitochondrial Concentrate Into Poor Quality Ova.

NCT01631578 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT01631578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01631578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of the Impact of Injecting an Autologous Somatic Mitochondrial Concentrate Into Poor Quality Ova.
Lead sponsor
Hadassah Medical Organization
Phase
Phase 1/2
Overall status
Withdrawn
Start date
January 31, 2012
Completion date
August 31, 2015
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

low ovarian reserve, poor quality oocytes